Clinical Trial Update: Study to Evaluate the Bronchoprotective Effects of a Single Dose of N6022 in Patients With Mild Asthma [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports results from a combined Phase 1/Phase 2 study evaluating the bronchoprotective effects of a single dose of N6022 in adults wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• N6022

Snippet

Sponsor: Nivalis Therapeutics, Inc. | Conditions: Asthma | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2014-03-11